Proteomics

Global Proteomics Market to Reach US$66.7 Billion by 2030

The global market for Proteomics estimated at US$37.4 Billion in the year 2024, is expected to reach US$66.7 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 11.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.8 Billion While China is Forecast to Grow at 12.8% CAGR

The Proteomics market in the U.S. is estimated at US$13.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Proteomics Market - Key Trends & Drivers Summarized

Proteomics is the large-scale study of proteins, their structures, functions, and interactions within a biological system. As proteins are essential to nearly every cellular process, proteomics provides crucial insights into how cells function and how diseases develop. Techniques used in proteomics include mass spectrometry, protein microarrays, and various bioinformatics tools to identify and quantify proteins, analyze protein modifications, and map protein-protein interactions. These techniques allow scientists to explore the proteome, the entire set of proteins produced by an organism, tissue, or cell. By comparing proteomes under different conditions, researchers can identify disease biomarkers, understand disease mechanisms, and develop targeted therapies, making proteomics indispensable in biomedical research.

Recent advancements in proteomics have significantly enhanced its capabilities and applications. High-resolution mass spectrometry and advanced bioinformatics tools have improved the accuracy and efficiency of protein identification and quantification. Innovations such as next-generation sequencing and CRISPR technology have facilitated the integration of proteomics with genomics and transcriptomics, providing a more comprehensive understanding of cellular processes. Additionally, the development of single-cell proteomics is opening new avenues for studying cellular heterogeneity and disease progression at an unprecedented resolution. These technological advancements are driving the adoption of proteomics in various fields, including drug discovery, personalized medicine, and clinical diagnostics, as they enable more precise and detailed analysis of the proteome.

The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market`s expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.

SCOPE OF STUDY:

The report analyzes the Proteomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Component (Reagents, Instruments, Services); Application (Drug Discovery, Disease Diagnosis, Other Applications)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 178 Featured) -

• Active Motif, Inc.
• 20/20 Genesystems, Inc.
• BG Medicine, Inc.
• BGI-Shenzhen
• Biodesix, Inc.
• Abbiotec LLC
• BioChain Institute, Inc.
• Arbor Vita Corporation
• Biomosaics, Inc.
• Advansta Inc.
• AYOXXA Biosystems GmbH
• AKESOgen, Inc.
• Biognosys
• Biorbyt
• BioAnalyte

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.